Diagnosis Screening method Perioperative consequences Cirrhotic cardiomyopathy (CCM) Echocardiography assessment of LV diastolic function Congestive heart failurea Hepatopulmonary syndrome (HPS) Room air hypoxemia (PaO2 <70 mmHg) in the absence of…
Phase of hemostasis Promote hemostasis Impair hemostasis Primary hemostasis (platelet activation) Increased VWF Decreased ADAMTS-13 Thrombocytopenia Secondary hemostasis (thrombin generation) Decreased protein C and S Decreased antithrombin III Increased factor…
Fig. 5.1 Serous cystic neoplasm. Axial unenhanced (a) and contrast-enhanced (b) CT images show a lobulated cystic lesion (arrowheads) in the pancreatic head with multiple thin internal septation and central…
Fig. 3.1 Primary MCN of the pancreas. The outer contour is smooth, but the internal structure is complex with cysts of varying size separated by thin walls. There is a…
Pseudocyst SCN MCN IPMN SPPT Lymphoepithelial cyst Cytologic findings “Dirty” material, macrophages, and other inflammatory cells Negative, or cellular sheets of glycogen-containing, cuboidal cells Mucin-containing columnar cells; small papillary…
© Springer-Verlag Italia 2015George H. Sakorafas, Vassileios Smyrniotis and Michael G. Sarr (eds.)Pancreatic Cystic Neoplasms10.1007/978-88-470-5708-1_1 1. Introduction to Pancreatic Cystic Neoplasms George H. Sakorafas1 , Vassileios Smyrniotis2 and Michael G. Sarr3 (1) Department of Surgical Oncology, Saint Savvas Cancer Hospital, Arkadias 19-21,…
Cystic neoplasms Serous cystic neoplasms (SCNs) Mucinous cystic neoplasms (MCNs) Intraductal papillary mucinous neoplasms (IPMNs) Uncommon cystic neoplasms Solid pseudopapillary neoplasm Cystic neuroendocrine neoplasms (functional and nonfunctional) Acinar cell cystadenocarcinoma…
MD-IPMNs Ideally, all main-duct and mixed variant IPMNs should be resected (in patients who are good surgical candidates with reasonable life expectancy) BD-IPMN Resection is indicated in the presence of…
© Springer-Verlag Italia 2015George H. Sakorafas, Vassileios Smyrniotis and Michael G. Sarr (eds.)Pancreatic Cystic Neoplasms10.1007/978-88-470-5708-1_7 7. Prognosis and Follow-Up George H. Sakorafas1 , Vassileios Smyrniotis2 and Michael G. Sarr3 (1) Department of Surgical Oncology, Saint Savvas Cancer Hospital, Arkadias 19-21, Athens, 11526,…
NIH system [15] University of Toronto System [16] Current authors Grade Features Grade Hepatic features Grade Immuno-suppression Grade Features 1, Silent Without change in ALT H0 No hepatitis, ALT <2 × ULN…
